Rankings
▼
Calendar
ARVN
Arvinas, Inc.
$856M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$6M
-378.5% margin
Net Income
-$6M
-374.3% margin
EPS (Diluted)
$-3.29
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
-$644
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$24M
Cash & Equivalents
-$36M
← FY 2017
All Quarters
Q2 2017 →
ARVN Q1 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena